119 related articles for article (PubMed ID: 21510752)
1. Comparing the enhancement efficiency between liposomes and microbubbles for insulin pulmonary absorption.
Xu YY; Lu CT; Fu HX; Zhao YZ; Yang W; Li X; Zhang L; Li XK; Zhang M
Diabetes Technol Ther; 2011 Jul; 13(7):759-65. PubMed ID: 21510752
[TBL] [Abstract][Full Text] [Related]
2. An in vivo experiment to improve pulmonary absorption of insulin using microbubbles.
Zhao YZ; Xu YY; Li X; Lu CT; Zhang L; Dai DD; Sun CZ; Lv HF; Li XK; Yang W
Diabetes Technol Ther; 2011 Oct; 13(10):1013-21. PubMed ID: 21745138
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the insulin-liposomes double-coated by chitosan and chitosan-EDTA conjugates].
Wu ZH; Ping QN; Song YM; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2004 Nov; 39(11):933-8. PubMed ID: 15696937
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary delivery of insulin lipid suspension].
Jiang ZQ; Lu J
Yao Xue Xue Bao; 2002 May; 37(5):378-82. PubMed ID: 12579846
[TBL] [Abstract][Full Text] [Related]
5. State of insulin self-association does not affect its absorption from the pulmonary route.
Hussain A; Ahsan F
Eur J Pharm Sci; 2005 Jun; 25(2-3):289-98. PubMed ID: 15911225
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles for pulmonary delivery of insulin.
Liu J; Gong T; Fu H; Wang C; Wang X; Chen Q; Zhang Q; He Q; Zhang Z
Int J Pharm; 2008 May; 356(1-2):333-44. PubMed ID: 18281169
[TBL] [Abstract][Full Text] [Related]
7. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.
Sayes CM; Reed KL; Warheit DB
Toxicol Sci; 2007 May; 97(1):163-80. PubMed ID: 17301066
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W
Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880
[TBL] [Abstract][Full Text] [Related]
9. [Effects of the liposomes coated by chitosan and its derivatives on the gastrointestinal transit of insulin].
Wu ZH; Ping QN; Lei XM; Li JY; Cai P
Yao Xue Xue Bao; 2005 Jul; 40(7):618-22. PubMed ID: 16196267
[TBL] [Abstract][Full Text] [Related]
10. Effects of phospholipid chain length, concentration, charge, and vesicle size on pulmonary insulin absorption.
Li Y; Mitra AK
Pharm Res; 1996 Jan; 13(1):76-9. PubMed ID: 8668683
[TBL] [Abstract][Full Text] [Related]
11. [The enhancing effect of tomato lectin modified liposomes of insulin on oral absorption in mice].
Zhang N; Ping QN; Xu WF
Yao Xue Xue Bao; 2004 May; 39(5):380-4. PubMed ID: 15338884
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human insulin microcrystals and their absorption enhancement by protease inhibitors in rat lungs.
Park SH; Kwon JH; Lim SH; Park HW; Kim CW
Int J Pharm; 2007 Jul; 339(1-2):205-12. PubMed ID: 17451895
[TBL] [Abstract][Full Text] [Related]
13. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X
Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Wu ZH; Ping QN; Wei Y; Lai JM
Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
[TBL] [Abstract][Full Text] [Related]
15. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
[TBL] [Abstract][Full Text] [Related]
16. Human insulin microcrystals with lactose carriers for pulmonary delivery.
Lim SH; Park HW; Shin CH; Kwon JH; Kim CW
Biosci Biotechnol Biochem; 2009 Dec; 73(12):2576-82. PubMed ID: 19966492
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary delivery of insulin by liposomal carriers.
Huang YY; Wang CH
J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
[TBL] [Abstract][Full Text] [Related]
18. [Enhancing effect of Ulex europaeus agglutinin I modified liposomes on oral insulin absorption in mice].
Zhang N; Ping QN; Xu WF
Yao Xue Xue Bao; 2004 Dec; 39(12):1006-10. PubMed ID: 15813031
[TBL] [Abstract][Full Text] [Related]
19. Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
Salmaso S; Bersani S; Elvassore N; Bertucco A; Caliceti P
Int J Pharm; 2009 Sep; 379(1):51-8. PubMed ID: 19545616
[TBL] [Abstract][Full Text] [Related]
20. Erythrocytes as oral delivery systems for human insulin.
Al-Achi A; Greenwood R
Drug Dev Ind Pharm; 1998 Jan; 24(1):67-72. PubMed ID: 15605599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
